12-Jan-2017 - The “NCI Formulary” enables investigators to obtain investigational agents for testing in new preclinical or clinical studies.
22-Nov-2016 - The new collaborative initiative will be led by QuintilesIMS, with founding partners including Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, and Pfizer.
15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.
12-Nov-2015 - WuXi PharmaTech will develop and manufacture a cardiovascular candidate for Eli Lilly in China through a strategic collaboration.
06-Aug-2015 - Eli Lilly on Tuesday cut ties with the University of California, San Diego (UCSD) as a legal battle between UCSD and the University of Southern California (USC) continues over the control of...
30-Jul-2015 - Despite expanding their in-house R&D facilities, both Pfizer and Eli Lilly say they remain committed to using CROs.
21-May-2015 - Reliance on CMOs and CROs has allowed the flexibility to make Gilead a top 10 pharma firm, and the use of third-parties will remain part of its strategy according to...
24-Apr-2015 - Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions
10-Apr-2015 - Industry group TransCelerate BioPharma has established two new global initiatives around placebo and standard of care data sharing, and electronic labels for clinical trials – both of which aim to...
20-Mar-2015 - Eli Lilly and China biotech Innovent Biologics will collaborate to develop at least three cancer treatments over the next decade.
05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...
06-Feb-2015 - When it comes to forging solid relationships between CMOs (contract manufacturing organizations) and drug developers, one thing is clear: deviations will occur.
19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
15-Dec-2014 - A Covance investor is raising questions over Goldman Sachs’ involvement in providing advice to the CRO’s board, which recently accepted a $6.1bn takeover offer from industry peer LabCorp.
08-Dec-2014 - INC Research has expanded its partnership with the Society for Clinical Research Sites (SCRS) through the end of 2015 to become the first organization to support SCRS' new member Scholarship...
02-Dec-2014 - Third-party manufacturers anxious about Big Biopharma investments and downbeat industry reports can relax as experts concur “it’s a time of growth for biopharmaceutical outsourcing.”
03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...
27-May-2014 - Eli Lilly is maintaining greater in-house control as manufacturing processes become more complex, whilst MSD is leveraging external over-capacity to fulfil its needs, the firms told Outsourcing-Pharma.com during a recent...
03-Jul-2013 - Performance monitoring should be applied equally to external manufacturing as internal operations, says Eli Lilly.
03-Jul-2013 - Collaboration and intelligence sharing has seen pharmaceutical cargo theft decline heavily since Lilly fell prey to an $80m heist in 2010, says industry expert.
29-May-2013 - Eli Lilly has selected another contractor to help develop companion diagnostics for its oncology pipeline.
07-Feb-2013 - Rexam says that expansion of its French plant is led by Lilly and the growing demand for insulin delivery products.
05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.
31-May-2012 - Covance has inked deals to provide preclinical services to Eli Lilly’s diabetes operations in China and late-stage support to Bayer Healthcare.
26-Jan-2012 - Jubilant Life Sciences has bought US drugmaker Eli Lilly’s stake in the early-stage development focused JV the firms set up in 2008.